News Conference News AHA 2024 One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024 Shelley Wood November 14, 2024
News Daily News Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden Caitlin E. Cox December 12, 2023
News Daily News Polypills Added to List of WHO’s Essential Medicines Michael O'Riordan August 02, 2023
Presentation Complex Coronary Cases 2023 A Link Between the Heart and the Brain: New Data on the Elderly Presenter: Valentin Fuster June 15, 2023
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Daily News Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained Yael L. Maxwell July 15, 2022
News Conference News TCT 2020 Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care L.A. McKeown October 26, 2020
News Conference News TCT 2020 Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19 Todd Neale October 14, 2020
News Daily News Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients Michael O'Riordan October 17, 2019
News Conference News AHA 2018 Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI Michael O'Riordan November 14, 2018
Presentation TCT 2018 Featured Lecture: Does the Polypill Enhance Drug Adherence and Improve Cardiovascular Outcomes? Presenter: John A. Bittl, C. Michael Gibson, Valentin Fuster September 23, 2018
News Conference News ACC 2018 ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins Shelley Wood March 10, 2018
News Features Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing Shelley Wood January 04, 2017
News Daily News Más Quelación: Se Aprueba el Ensayo TACT2 para el Controvertido Tratamiento Post-IM en Pacientes Diabéticos Shelley Wood September 28, 2016
News Daily News Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy Michael O'Riordan August 23, 2016
News Daily News Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients L.A. McKeown August 11, 2016
News Daily News El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI L.A. McKeown August 11, 2016
News Daily News Even a Little Exercise Yields Big Benefits, but Harm Unlikely at High Activity Levels Michael O'Riordan January 18, 2016
Presentation TCT 2014 TCT 127: Incidence, Predictors, and Prognostic Impact of Postdischarge Bleeding After Percutaneous Coronary Intervention Presenter: Valentin Fuster, Philippe Généreux September 13, 2014